Chemists have found a way to make a naturally occurring enzyme take on a new, artificial role, which has significant implications for modern chemistry, including pharmaceutical production. Princeton chemists have found a way to make a naturally occurring enzyme take on a new, artificial role, which has significant implications for modern chemistry, including pharmaceutical production. The study was published in the journal Nature Chemistry.
All news from Anaesthesiology
A systematic approach (edited by Dr. Syuichi Koarada) comprehensively covers each aspect of the pathology, diagnosis, and treatment of rheumatoid arthritis
A study led by Luísa Lopes, Group Leader at Instituto de Medicina Molecular João Lobo Antunes and published today in the prestigious journal Molecular Psychiatry, describes a new mechanism involved in memory loss associated with aging
A recent study suggests that an easy-to-use, non-invasive method can produce reproducible estimates of arterial stiffness in adolescents aged 16-19 years. The results of the study, conducted at the University of Jyväskylä, were published in the journal Clinical Physiology and Functional Imaging
In a consulting room in Togo's capital, Lome, Geraldo Emmanuel—handicapped since birth six years ago—waits patiently on a bed while a digital scan is taken of his right leg. Thanks to new 3D technology, he may be able to walk normally within a few months.?????
Patients with Down syndrome (DS) have steeper and thinner corneas and more corneal aberrations than patients without DS, according to a study published online June 21 in JAMA Ophthalmology
The World Health Organization (WHO) has said that a new heat-stable version of a drug Carbetocin can save lives of new mothers could “revolutionize” therapy. The results of the study looking at the effectiveness of the new version of the drug were published in the latest issue of the New England Journal of Medicine
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to radionuclide therapy targeting prostate-specific membrane antigen (PSMA) with the radionuclide lutetium-177 (177Lu)
It may soon be possible to reverse a genetic form of autism spectrum disorder (ASD) by using drugs initially developed to treat cancer. A team of researchers, led by Professor Riccardo Brambilla from Cardiff University, discovered that an experimental drug can potentially treat, and even permanently reverse, the symptoms associated with a genetic form of ASD
Chronic kidney disease (CKD) is a major global health problem. Unless intensive intervention is initiated, some patients can rapidly progress to end-stage kidney disease. However, it is often difficult to predict renal outcomes using conventional laboratory tests in individuals with CKD. Therefore, many researchers have been searching for novel biomarkers to predict the progression of CKD
Researchers in Sweden have shown how data-driven AI could contribute to a better understanding of how prostate cancer develops, and even improve clinical diagnosis and treatment of the disease
The nonprofit advocacy group Public Citizen has asked the US Food and Drug Administration (FDA) to immediately pull the gout drug febuxostat (Uloric, Takeda Pharmaceuticals) from the market following results of a large postmarketing study that showed higher rates of fatal cardiovascular (CV) events and all-cause mortality in patients taking the drug